Pharmacogenomics (PGx) Testing for Military Readiness Pilot
ID: MTEC-25-PGxType: Presolicitation
Overview

Buyer

DEPT OF DEFENSEDEFENSE HEALTH AGENCY (DHA)ARMY MED RES ACQ ACTIVITYFORT DETRICK, MD, 21702, USA

NAICS

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) (541715)

PSC

HEALTH R&D SERVICES; HEALTH CARE - OTHER; EXPERIMENTAL DEVELOPMENT (AN43)

Original Source

https://sam.gov/opp/bcf747ec74904a73969865425913fa1a/view
Timeline
  1. 1
    Posted Apr 14, 2025, 12:00 AM UTC
  2. 2
    Updated Apr 14, 2025, 12:00 AM UTC
  3. 3
    Due May 14, 2025, 4:00 PM UTC
Description

The Department of Defense, through the Defense Health Agency (DHA), is seeking proposals for a pilot program focused on pharmacogenomics (PGx) testing to enhance military readiness and healthcare delivery for Active-Duty service members. The initiative aims to establish standardized processes for routine PGx testing within the Military Health System (MHS), leveraging electronic health record (EHR) data to improve clinical decision-making and treatment outcomes. This program is critical for optimizing medication safety and efficacy, ultimately preventing adverse drug reactions and improving overall health conditions for military personnel. Interested parties should contact Dr. Lauren Palestrini at lauren.palestrini@mtec-sc.org, with a funding availability of $2.2 million and a project duration of up to 36 months. The Request for Project Proposals (RPP) is expected to be released soon, with a proposal preparation period of approximately 30 days.

Point(s) of Contact
Dr. Lauren Palestrini
lauren.palestrini@mtec-sc.org.
Files
Title
Posted
MTEC-25-PGX_Pre-Announcement.pdf
Apr 14, 2025, 12:05 PM UTC
The Medical Technology Enterprise Consortium (MTEC) has issued a pre-announcement for a Request for Project Proposals (RPP) aimed at launching a pilot program on pharmacogenomics (PGx) testing within the Military Health System (MHS). This initiative responds to the FY24 DoD Appropriations Act and seeks to enhance medical treatment for Active-Duty service members (ADSMs) and ultimately improve military readiness. The pilot program will demonstrate standardized processes for routine PGx testing, leveraging electronic health record (EHR) data to inform clinical decision-making and improve healthcare delivery. Key objectives include fostering collaboration with Military Treatment Facilities, integrating PGx into clinical care, and evaluating treatment outcomes relating to drug efficacy and safety. Proposals must be submitted by a qualified team that includes clinical pharmacists experienced in PGx and compliant with government data access requirements. The funding availability for the program stands at $2.2 million, with a project duration of up to 36 months for successful proposals. MTEC's overarching mission is to facilitate advanced medical technology solutions for military personnel, ensuring they receive optimized healthcare. This pilot program highlights the Department of Defense’s commitment to employing precision medicine in enhancing the effectiveness and safety of medical interventions for its service members.
Lifecycle
Title
Type
Pharmacogenomics (PGx) Testing for Military Readiness Pilot
Currently viewing
Presolicitation
Similar Opportunities
Genetic Testing Services for Tripler Army Medical Center, HI
Buyer not available
The Department of Defense, through the Medical Readiness Contracting Office - Pacific, is seeking qualified contractors to provide genetic testing services for the Tripler Army Medical Center in Hawaii. This procurement aims to establish a Blanket Purchase Agreement (BPA) for these services, which are critical for supporting the healthcare needs of military personnel and their families. The BPA will have a total not-to-exceed value of $500,000 and a performance period from September 8, 2025, to September 7, 2030, with quotes due by May 6, 2025, at 10:00 AM HST. Interested parties should contact Ms. Deborah Wada at deborah.n.wada.civ@health.mil or call 808-433-9520 for further details.
Remote Health Readiness Program 4 (RHRP-4)
Buyer not available
The Department of Defense, through the Defense Health Agency (DHA), is soliciting proposals for the Remote Health Readiness Program 4 (RHRP-4), aimed at providing comprehensive medical and dental readiness services to military personnel, including active and reserve components, as well as Department of Homeland Security members. The contract, structured as an Indefinite Delivery Indefinite Quantity (IDIQ) agreement, will span ten years and is valued at a maximum of $1.61 billion, focusing on maintaining the health and readiness of service members through various assessments, treatments, and logistical support. This initiative underscores the importance of ensuring a medically ready force, with contractors required to establish a network of certified providers and adhere to strict quality control and reporting standards. Interested parties must submit their proposals by May 9, 2025, and can direct inquiries to Nakaura C. Yusuf at nakaura.c.yusuf.civ@health.mil or by phone at 703-681-5821.
Department of Defense Pharmacy Uniform Formulary Blanket Purchase Agreement/ Uniform Formulary Additional Discount Program
Buyer not available
The Department of Defense (DoD) is seeking pharmaceutical manufacturers to participate in a Request for Quotation (RFQ) for the Uniform Formulary Blanket Purchase Agreement (UF BPA) and the Uniform Formulary Additional Discount Program (UF ADP) as part of its integrated pharmacy benefits program for the Military Health System (MHS). The procurement aims to evaluate and select pharmaceutical agents based on their clinical and cost-effectiveness for inclusion in the DoD Uniform Formulary, with specific focus on newly approved drugs in categories such as analgesics, antihemophilic agents, benign prostatic hyperplasia agents, and nephrology agents. Interested vendors must submit their quotes by May 15, 2025, and participate in a pre-quotation teleconference scheduled for May 6, 2025, with further details available in the attached RFQ document. For inquiries, vendors can contact Julia Trang at julia.n.trang.civ@health.mil or Stephanie Erpelding at stephanie.j.erpelding.civ@health.mil.
Department of Defense Pharmacy Uniform Formulary Blanket Purchase Agreement/Uniform Formulary Additional Discount Program
Buyer not available
The Department of Defense, through the Defense Health Agency, is soliciting quotes for the Pharmacy Uniform Formulary Blanket Purchase Agreement and the Uniform Formulary Additional Discount Program, aimed at establishing an effective pharmacy benefits program for the Military Health System. This procurement involves the evaluation and selection of pharmaceutical agents based on their clinical and cost-effectiveness, with a focus on newly approved drugs that will be reviewed by the Pharmacy and Therapeutics Committee in February 2025. Interested vendors must submit their pricing information, including National Drug Codes (NDCs), by December 19, 2024, and are encouraged to participate in a pre-quotation teleconference on December 4, 2024. For further inquiries, vendors can contact Tracy Banks at tracy.e.banks2.civ@mail.mil or Julia Trang at julia.n.trang.civ@health.mil.
Drug Testing Kits
Buyer not available
The Department of Defense, specifically the Marine Corps Recruiting Command, is seeking proposals for the provision of single-use instant drug testing kits to be utilized at Military Entrance Processing Stations (MEPS) during the enlistment process. The kits must meet specific drug detection parameters, including testing for various substances at designated cutoff levels and incorporating built-in validity tests. This procurement is crucial for standardizing drug testing processes within military enlistment, ensuring compliance with federal regulations and operational efficiency, with an estimated total requirement of 477,200 kits over a five-year period. Interested HUBZone small businesses must submit their proposals by May 2, 2025, and can direct inquiries to Dedriene Green at dedriene.l.green.civ@usmc.mil or Kacy Mohead at kacy.m.mohead@usmc.mil.
Health Care Delivery IT Solutions (MHS GENESIS) Documentation
Buyer not available
The Department of Defense, through the Defense Health Agency (DHA), is seeking small businesses to provide documentation services for the MHS GENESIS electronic health record system. The primary objective is to revise and update existing technical documentation to ensure it is comprehensive and understandable for third parties, facilitating future responses to requests for proposals (RFPs) and ongoing maintenance of the system. MHS GENESIS is a complex system that integrates various health record components and serves over 9.6 million beneficiaries, making accurate documentation critical for operational efficiency and compliance. Interested parties must submit their capability statements by April 28, 2025, to the designated email address, with a maximum of seven pages for their response.
GLOBAL NURSE ADVICE LINE RFI/ INDUSTRY DAY
Buyer not available
The Department of Defense, through the Defense Health Agency (DHA), is seeking proposals for the Global Nurse Advice Line-Next Generation (GNAL-NG), a telehealth service aimed at providing 24/7 access to registered nurses for triage, self-care advice, and care coordination for eligible Military Health System beneficiaries. The contractor will be responsible for delivering high-quality telehealth services, ensuring interoperability with existing military health systems, and achieving specific performance metrics, such as answering calls within 90 seconds and maintaining a low abandonment rate. This initiative is critical for enhancing healthcare delivery within the Military Health System, ultimately improving access to care for service members and their families. Interested parties must submit their proposals in accordance with the specified guidelines by the due date, with the anticipated contract award scheduled for April 2025. For further inquiries, contact Nakaura C. Yusuf at nakaura.c.yusuf.civ@health.mil or (703) 681-5821.
Generally Unconstrained Intelligence Drug Engineering (GUIDE) collaboration between U.S. interagency, academic and industry partners
Buyer not available
The Department of Defense, specifically the U.S. Army, is seeking collaboration with qualified entities for the Generally Unconstrained Intelligence Drug Engineering (GUIDE) program, aimed at accelerating the development of medical countermeasures for warfighters. This initiative involves a partnership among U.S. interagency, academic, and industry stakeholders to leverage advanced simulation and machine learning technologies for the rapid design and optimization of biological products and small molecule drugs. The GUIDE program is critical for enhancing the preparedness and response capabilities against diverse threats, and interested parties must demonstrate technical relevance by contacting the primary point of contact, Joseph McCaffery, at joseph.w.mccaffery2.civ@army.mil. Participation is governed by a Participant Basic Agreement (PBA), and entities must be registered in the System for Award Management (SAM) prior to any award.
Repaglinide
Buyer not available
Presolicitation DEPT OF DEFENSE is planning to issue a national requirements contract for Repaglinide Tablets. The contract will establish a national supply source for the purchase of Repaglinide 0.5MG, 1MG, and 2MG in 100 count bottles. This acquisition will be unrestricted and fully competitive. The contract will be a firm-fixed price, requirements type contract with a one year base and four one year options. The items listed in the schedule will be purchased by Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons customers through the DLA and VA prime vendor programs. Interested parties should contact Phyllis Daraio for any questions/comments. The projected solicitation date is September 2020.
On Island Reference Laboratory Testing and Courier Services at Triple Army Medical Center, Hawaii
Buyer not available
The Department of Defense, through the Medical Readiness Contracting Office – Pacific, is soliciting proposals for On Island Reference Laboratory Testing and Courier Services at Tripler Army Medical Center in Hawaii. The procurement aims to establish Multiple Blanket Purchase Agreements for non-personal laboratory services that support medical diagnostics and patient care for military beneficiaries, including STAT courier services for urgent testing and compliance with strict professional standards. This initiative is crucial for ensuring accessible and high-quality laboratory services tailored to the needs of the armed forces and their families. Interested parties must submit their quotes via email to Leslie Takayama at leslie.m.takayama.civ@health.mil by April 30, 2025, at 10:00 am HST, with a total contract value limit of $250,000.